Pierre Beaurang

Pierre Beaurang has recently been appointed as the new Strategy and Business Development Advisor for Oryzon Genomics, bringing extensive experience from his previous roles as CEO of Nitrase Therapeutics and Director of Business at Nurix Therapeutics, focusing on neurodegenerative disorders and cancer.